(HealthDay)—Pioglitazone may not be effective for lowering blood glucose levels, although it is associated with slight improvement in liver function, in lipoatrophic diabetes induced by juvenile dermatomyositis, according ...
0
0
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective ...
2
0
(HealthDay)—In patients with type 2 diabetes being treated with a dipeptidyl peptidase-4 inhibitor (DPP4-I), use of anagliptin (ANA) may improve low-density lipoprotein cholesterol (LDL-C) levels, with the effect mediated, ...
1
0
(HealthDay)—For pregnant women with type 1 diabetes, use of continuous glucose monitoring (CGM) is associated with improved neonatal outcomes, according to a study published online Sept. 15 in The Lancet to coincide with ...
6
0
(HealthDay)—For adolescents with type 1 diabetes (T1D), a closed-loop control (CLC) system is associated with improved glycemic control and reduced exposure to hypoglycemia during prolonged exercise, cold temperatures, ...
0
0
